Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Can orthopedic surgeons help create a better head start for osteoporosis treatment after hip fracture?

Rinat B, Rubin G, Orbach H, Giwnewer U, Rozen N.

Medicine (Baltimore). 2016 Jul;95(27):e4141. doi: 10.1097/MD.0000000000004141.

2.

Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study.

Viprey M, Caillet P, Canat G, Jaglal S, Haesebaert J, Chapurlat R, Schott AM.

PLoS One. 2015 Dec 2;10(12):e0143842. doi: 10.1371/journal.pone.0143842. eCollection 2015.

3.

Alendronate and raloxifene therapy in the early period after hip fracture.

Ohishi T, Ichikawa T, Ito T, Koyama H, Miyagi M, Hoshino H, Takahashi M.

J Rural Med. 2011;6(1):16-21. doi: 10.2185/jrm.6.16.

4.

Undertreatment of osteoporosis following hip fractures in jeju cohort study.

Kim SR, Park YG, Kang SY, Nam KW, Park YG, Ha YC.

J Bone Metab. 2014 Nov;21(4):263-8. doi: 10.11005/jbm.2014.21.4.263. Epub 2014 Nov 30.

5.

Incidence and risk factors of subsequent hip fractures in Korea: multicenter study.

Lee KH, Kim JY, Yim SJ, Moon DH, Choi GH, Moon KH.

J Korean Med Sci. 2014 Jul;29(7):992-4. doi: 10.3346/jkms.2014.29.7.992. Epub 2014 Jul 11.

6.

Maximising functional recovery following hip fracture in frail seniors.

Beaupre LA, Binder EF, Cameron ID, Jones CA, Orwig D, Sherrington C, Magaziner J.

Best Pract Res Clin Rheumatol. 2013 Dec;27(6):771-88. doi: 10.1016/j.berh.2014.01.001. Review.

7.

Appropriate osteoporosis treatment by family physicians in response to FRAX vs CAROC reporting: results from a randomized controlled trial.

Beattie KA, Ioannidis G, MacDermid JC, Grewal R, Papaioannou A, Adachi JD, Hodsman AB.

J Clin Densitom. 2014 Oct-Dec;17(4):458-65. doi: 10.1016/j.jocd.2013.09.007. Epub 2013 Oct 25.

8.

Prevention and clinical management of hip fractures in patients with dementia.

Menzies IB, Mendelson DA, Kates SL, Friedman SM.

Geriatr Orthop Surg Rehabil. 2010 Nov;1(2):63-72. doi: 10.1177/2151458510389465.

9.

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy JM, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH.

J Bone Joint Surg Am. 2013 Feb 20;95(4):297-307. doi: 10.2106/JBJS.K.01181. Review.

10.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

11.

Participation in high-impact sports predicts bone mineral density in senior olympic athletes.

Leigey D, Irrgang J, Francis K, Cohen P, Wright V.

Sports Health. 2009 Nov;1(6):508-13.

12.

Subsequent hip fracture in osteoporotic hip fracture patients.

Lee SH, Lee TJ, Cho KJ, Shin SH, Moon KH.

Yonsei Med J. 2012 Sep;53(5):1005-9. doi: 10.3349/ymj.2012.53.5.1005.

13.

Orthopedic surgeon's awareness can improve osteoporosis treatment following hip fracture: a prospective cohort study.

Kim SR, Ha YC, Park YG, Lee SR, Koo KH.

J Korean Med Sci. 2011 Nov;26(11):1501-7. doi: 10.3346/jkms.2011.26.11.1501. Epub 2011 Oct 27.

14.

The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC).

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.

BMC Med Educ. 2009 Aug 6;9:54. doi: 10.1186/1472-6920-9-54.

15.

Family physicians' personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.

Popul Health Manag. 2009 Jun;12(3):131-8. doi: 10.1089/pop.2008.0025.

16.

Osteoporosis management among residents living in long-term care.

Giangregorio LM, Jantzi M, Papaioannou A, Hirdes J, Maxwell CJ, Poss JW.

Osteoporos Int. 2009 Sep;20(9):1471-8. doi: 10.1007/s00198-009-0837-x. Epub 2009 Feb 10.

17.

Optimizing care in osteoporosis: the Canadian quality circle project.

Ioannidis G, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Salach L, Jiwa F, Adachi JD, Papaioannou A.

BMC Musculoskelet Disord. 2008 Oct 1;9:130. doi: 10.1186/1471-2474-9-130.

18.

Canadian Quality Circle pilot project in osteoporosis: rationale, methods, and feasibility.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Baldwin A, Doupe M, Katz A, Salach L, Adachi JD.

Can Fam Physician. 2007 Oct;53(10):1694-700. Erratum in: Can Fam Physician. 2007 Dec;53(12):2105.

19.

Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention.

Levine DA, Saag KG, Casebeer LL, Colon-Emeric C, Lyles KW, Shewchuk RM.

J Am Med Dir Assoc. 2006 Sep;7(7):420-5. Epub 2006 Jul 17.

20.

Treatment of osteoporosis in an older home care population.

Vik SA, Maxwell CJ, Hanley DA.

BMC Musculoskelet Disord. 2005 Feb 11;6:7.

Supplemental Content

Support Center